AKASA
We're Hiring!
AKASA Company Growth, Stability & Outlook
What People Are Saying About AKASA
-
Strategic Partnerships: Cleveland Clinic expanded systemwide use of AKASA’s coding tools and later added CDI, and AKASA has a collaboration with Cerner/Oracle Health. These relationships indicate enterprise validation and distribution fit within major EHR ecosystems.
-
Product Line Growth: New GenAI offerings such as Authorization Advisor, Medical Coding, and a CDI Optimizer were launched across 2024–2025. This signals expansion from back‑end automation into mid‑cycle accuracy and documentation capabilities.
-
Investor Backing & Capital Strength: The company secured a sizable funding round in 2024 and reports significant total capital raised. This capitalization supports continued product development and go‑to‑market scaling.
